BioXcel’s phase 3 schizophrenia film has blockbuster potential, say analystsA sublingual film for acute agitation in schizophrenia and bipolar disorder from BioXcel has blockbuster potential that could Share XBioXcel’s phase 3 schizophrenia film has blockbuster potential, say analystshttps://pharmaphorum.com/news/bioxcel/
BioXcel to trial Apple Watch-drug combination to prevent Alzheimer’s agitation episodesUS biotech BioXcel Therapeutics hopes to use wearable digital devices such as the Apple Watch to predict whether Share XBioXcel to trial Apple Watch-drug combination to prevent Alzheimer’s agitation episodeshttps://pharmaphorum.com/news/bioxcel-to-trial-apple-watch-drug-combination-to-prevent-alzheimers-agitation-episodes/
BioXcel’s agitation drug gets FDA Fast TrackThe FDA has granted Fast Track Designation to BioXcel Therapeutics’ BXCL501 for the treatment of acute agitation resulting Share XBioXcel’s agitation drug gets FDA Fast Trackhttps://pharmaphorum.com/news/bioxcels-agitation-drug-gets-fda-fast-track/
